Allogene Therapeutics (ALLO) Stock Research

Over a week ago

Allogene gets RMAT, Fast Track designations for cemacabtagene ansegedleucel

ALLO

Jul 29, 8:52 AM

Allogene publishes Phase 1 data in Journal of Clinical Oncology

ALLO

Jul 15, 9:24 AM

Citizens biotech analyst holds an analyst/industry conference call

Jul 6, 2:30 PM

Citizens biotech analysts hold an analyst/industry conference call

Jul 2, 3:21 PM

Allogene Therapeutics says Zachary Roberts to succeed David Chang as CEO

ALLO

May 28, 5:04 PM

Allogene Therapeutics increases 2026 operating cash expense guidance

ALLO

May 13, 4:14 PM

Allogene Therapeutics reports Q1 EPS (18c), consensus (18c)

ALLO

May 13, 4:13 PM

Allogene Therapeutics options imply 10.6% move in share price post-earnings

ALLO

May 13, 3:11 PM

Allogene Therapeutics expands Phase 2 ALPHA3 trial to South Korea, Australia

ALLO

Apr 21, 8:43 AM

Allogene Therapeutics price target lowered by $1 at H.C. Wainwright, here's why

ALLO

Apr 16, 6:08 AM

Allogene Therapeutics just upgraded at JPMorgan, here's why

ALLO

Apr 16, 5:22 AM

Allogene Therapeutics price target raised by $4 at Jefferies, here's why

ALLO

Apr 15, 12:03 PM

Unusually active option classes on open April 15th

Apr 15, 9:40 AM

Allogene Therapeutics 87.5M share Spot Secondary priced at $2.00

ALLO

Apr 14, 9:56 PM

Allogene Therapeutics price target raised by $2.25 at Bernstein, here's why

ALLO

Apr 14, 7:44 AM

Allogene Therapeutics price target raised by $2 at Baird, here's why

ALLO

Apr 14, 7:28 AM

Allogene Therapeutics price target raised by $4 at H.C. Wainwright, here's why

ALLO

Apr 14, 6:10 AM

Allogene Therapeutics price target raised by $3 at Citizens, here's why

ALLO

Apr 14, 5:49 AM

Cellectis highlights Allogene ALPHA3 trial data, potential milestone payments

Apr 13, 4:41 PM

Allogene Therapeutics announces $175M common stock offering

ALLO

Apr 13, 4:33 PM

What You Missed On Wall Street On Monday

+30

Apr 13, 4:30 PM

Midday Fly By: Goldman reports Q1 beat, Baker Hughes to sell Waygate

+26

Apr 13, 12:00 PM

Morning Movers: Leggett & Platt gains, Somnigroup lower after $2.5B deal

Apr 13, 9:00 AM